Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
Panke Qu, Julia N. Faraone, John P. Evans, Xue Zou, Yi-Min Zheng, Claire Carlin, Joseph S. Bednash, Gerard Lozanski, Rama K. Mallampalli, Linda J. Saif, Eugene M. Oltz, Peter J. Mohler, Richard J. Gumina, Shan‐Lu Liu
Abstract
To characterize infection-induced immunity and vaccine-induced immunity against newly emerged omicron subvariants.
Topics & Concepts
NeutralizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakBiologyMedicineVirusInfectious disease (medical specialty)PathologyOutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingInfectious Encephalopathies and Encephalitis